IDEX Health & Science, LLC today announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.

Located in Zweibrücken, Germany, thinXXS Microtechnology is a leader in the development and production of plastic microfluidic consumables serving the Life Sciences, Point of Care, and Veterinary markets. This acquisition will serve to establish IDEX Health & Science as the leader in microfluidic technologies, and sharpen its focus on the growth of integrated optofluidic sub-systems, components, and highly engineered solutions across its target markets.

Commenting on the acquisition, IDEX Health & Science President Gus Salem stated, “thinXXS is our second microfluidic asset acquisition that represents an incremental building block to our microfluidic technologies platform.” Salem continued, “The company’s market-leading technology and product portfolio are a fantastic fit with our microfluidics growth strategy by providing greater access to our core life science instrumentation market and creating new growth opportunities within the Point of Care, and Veterinary markets.”

more about IDEX